Clinuvel Pharmaceuticals Ltd Net Asset Quality Index
Clinuvel Pharmaceuticals Ltd net asset quality index. Clinuvel Pharmaceuticals Ltd (CUV) has a Net Asset Quality Index of 92.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of AU$269.70 Million minus total liabilities of AU$20.68 Million yields net assets of AU$249.02 Million. A higher index indicates a stronger, lower-leverage balance sheet. See what is Clinuvel Pharmaceuticals Ltd's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Clinuvel Pharmaceuticals Ltd (2000–2025)
Net asset quality index of Clinuvel Pharmaceuticals Ltd from 2000 to 2025. This chart shows how Clinuvel Pharmaceuticals Ltd's Net Asset Quality Index has evolved across 26 annual periods from 2000 to 2025. As of December 2025, the index stands at 92.3%, representing net assets of AU$249.02 Million against total assets of AU$269.70 Million AUD. Check Clinuvel Pharmaceuticals Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Clinuvel Pharmaceuticals Ltd Net Asset Quality Index by Year (2000–2025)
Clinuvel Pharmaceuticals Ltd net asset quality index by year from 2000 to 2025. The table below presents the year-by-year Net Asset Quality Index for Clinuvel Pharmaceuticals Ltd from 2000 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Clinuvel Pharmaceuticals Ltd.
| Year | Quality Index | Net Assets (AUD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.6% | AU$240.81 Million | AU$271.75 Million | AU$30.94 Million | ▲ +0.8 pp |
| 2024 | 87.8% | AU$203.01 Million | AU$231.12 Million | AU$28.11 Million | ▲ +3.2 pp |
| 2023 | 84.6% | AU$164.63 Million | AU$194.52 Million | AU$29.89 Million | ▼ -2.1 pp |
| 2022 | 86.7% | AU$125.56 Million | AU$144.81 Million | AU$19.25 Million | ▼ -4.2 pp |
| 2021 | 90.9% | AU$98.74 Million | AU$108.57 Million | AU$9.83 Million | ▲ +2.6 pp |
| 2020 | 88.4% | AU$72.07 Million | AU$81.54 Million | AU$9.48 Million | ▼ -3.3 pp |
| 2019 | 91.7% | AU$57.18 Million | AU$62.35 Million | AU$5.17 Million | ▼ -0.2 pp |
| 2018 | 91.9% | AU$39.42 Million | AU$42.90 Million | AU$3.49 Million | ▲ +2.9 pp |
| 2017 | 88.9% | AU$25.44 Million | AU$28.61 Million | AU$3.16 Million | ▲ +0.4 pp |
| 2016 | 88.6% | AU$17.83 Million | AU$20.14 Million | AU$2.30 Million | ▲ +6.4 pp |
| 2015 | 82.1% | AU$11.21 Million | AU$13.64 Million | AU$2.44 Million | ▼ -7.8 pp |
| 2014 | 89.9% | AU$15.43 Million | AU$17.15 Million | AU$1.73 Million | ▲ +2.4 pp |
| 2013 | 87.5% | AU$13.84 Million | AU$15.81 Million | AU$1.98 Million | ▲ +2.3 pp |
| 2012 | 85.3% | AU$13.64 Million | AU$16.00 Million | AU$2.36 Million | ▲ +3.9 pp |
| 2011 | 81.4% | AU$16.41 Million | AU$20.17 Million | AU$3.76 Million | ▼ -8.2 pp |
| 2010 | 89.6% | AU$26.43 Million | AU$29.51 Million | AU$3.08 Million | ▲ +0.5 pp |
| 2009 | 89.0% | AU$37.05 Million | AU$41.61 Million | AU$4.56 Million | ▼ -5.2 pp |
| 2008 | 94.3% | AU$51.81 Million | AU$54.97 Million | AU$3.16 Million | ▼ -2.2 pp |
| 2007 | 96.4% | AU$65.39 Million | AU$67.82 Million | AU$2.43 Million | ▲ +14.5 pp |
| 2006 | 81.9% | AU$13.99 Million | AU$17.07 Million | AU$3.08 Million | ▲ +7.8 pp |
| 2005 | 74.1% | AU$7.45 Million | AU$10.06 Million | AU$2.60 Million | ▼ -12.3 pp |
| 2004 | 86.4% | AU$8.85 Million | AU$10.25 Million | AU$1.39 Million | ▼ -7.0 pp |
| 2003 | 93.4% | AU$7.53 Million | AU$8.07 Million | AU$535.45K | ▼ -4.6 pp |
| 2002 | 98.0% | AU$10.31 Million | AU$10.52 Million | AU$210.83K | ▲ +0.3 pp |
| 2001 | 97.7% | AU$13.45 Million | AU$13.77 Million | AU$318.26K | ▼ -1.5 pp |
| 2000 | 99.2% | AU$15.32 Million | AU$15.44 Million | AU$123.54K | — |